Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86462 | Target Info | |||
Target Name | Transthyretin (TTR) | ||||
Synonyms | TBPA; Prealbumin; PALB; ATTR | ||||
Target Type | Successful Target | ||||
Gene Name | TTR | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | CHF-5074 | Ligand Info | |||
Canonical SMILES | C1CC1(C2=CC(=C(C=C2)C3=CC(=C(C=C3)Cl)Cl)F)C(=O)O | ||||
InChI | 1S/C16H11Cl2FO2/c17-12-4-1-9(7-13(12)18)11-3-2-10(8-14(11)19)16(5-6-16)15(20)21/h1-4,7-8H,5-6H2,(H,20,21) | ||||
InChIKey | LIYLTQQDABRNRX-UHFFFAOYSA-N | ||||
PubChem Compound ID | 9996409 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6R6I Crystal structure of transthyretin mutant A25T in complex with CHF5074, a flurbiprofen analogue | ||||||
Method | X-ray diffraction | Resolution | 1.47 Å | Mutation | Yes | [1] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPTINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
||||||
PDB ID: 4I85 Crystal structure of transthyretin in complex with CHF5074 at neutral pH | ||||||
Method | X-ray diffraction | Resolution | 1.67 Å | Mutation | No | [2] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
||||||
PDB ID: 4I87 Crystal structure of TTR variant I84S in complex with CHF5074 at acidic pH | ||||||
Method | X-ray diffraction | Resolution | 1.69 Å | Mutation | Yes | [2] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGSSPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structure-activity relationships of flurbiprofen analogues as stabilizers of the amyloidogenic protein transthyretin. J Struct Biol. 2019 Nov 1;208(2):165-173. | ||||
REF 2 | Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors. FEBS Lett. 2013 Aug 2;587(15):2325-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.